Navigation Links
Campbell Alliance Business Development Practice to Moderate Two Workshops at LES Annual Meeting in Vancouver
Date:10/12/2007

RALEIGH, N.C., Oct. 12 /PRNewswire/ -- Campbell Alliance, the leading management consulting firm specializing in the pharmaceutical and biotechnology industries, today announced that Ben Bonifant, Vice President of the firm's Business Development (BD) practice, will moderate two workshops at the Licensing Executive Society (LES) Annual Meeting. The event will be held on October 14-18, 2007 at the Vancouver Convention and Exhibit Centre in Vancouver, Canada.

Mr. Bonifant's first workshop, titled "Building the Business Development Function from the Ground Up at a Growth-Orientated Pharmaceutical Company," will discuss the three key areas of building a first-rate BD function: strategy development, assessment and action, and opportunity generation. The workshop is scheduled for Tuesday, October 16 at 3:45 pm and will include participation from four senior BD executives representing global pharmaceutical and biotech companies.

Mr. Bonifant's second workshop, titled "Understanding the Regional Differences in Deal Making," will be held on Wednesday, October 17 at 2:00 pm. Mr. Bonifant, along with three pharmaceutical and biotech BD and licensing executives, will discuss critical considerations for BD professionals when executing regional deals, as well as country-specific differences for evaluating licensing opportunities. Delegates attending this session will hear firsthand case studies from companies that have successfully executed regional deals across various therapeutic areas.

Mr. Bonifant has been a management consultant for nearly 15 years, helping leaders of global pharmaceutical and biotech organizations and decision makers in large private equity funds. His perspectives on developments in the life sciences market are frequently published in industry and strategy journals, and he is a frequent guest lecturer at some of the nation's premier universities. Mr. Bonifant earned an MBA from the Stanford Graduate School of Business.

For more information on the LES Annual Meeting, please visit http://www.usa-canada.les.org/meetings/2007annual/.

Executives from Campbell Alliance speak at many conferences in the US and Europe each year. For a full listing of events, please refer to the company's online conference calendar at http://www.campbellalliance.com/pressroom/eventcalendar.cfm.

About the Business Development Practice at Campbell Alliance

The Business Development practice at Campbell Alliance helps licensing executives achieve an edge over the competition. Our consultants provide experienced counsel to clients who need assistance developing BD strategies, identifying partners, prioritizing targets, evaluating opportunities, and negotiating deals.

The firm's team includes seasoned consultants and industry professionals in pharmaceutical and biotech BD who have identified, assessed, and executed numerous in-licensing deals. They have also been valuable in aiding out- licensors, helping clients improve internal processes for pharmaceutical business development, and assisting top executives in charting new strategies in corporate development.

About Campbell Alliance

Campbell Alliance is the leading management consulting firm specializing in the pharmaceutical and biotechnology industries. The firm's clients include most of the world's top 20 pharmaceutical companies, as well as numerous emerging and midsize firms. Campbell Alliance is organized into practice areas, each specializing in a critical industry function, including Brand Management, Business Development, Clinical Development, Managed Markets, and Sales. From its locations in Raleigh, N.C., Parsippany, N.J., Los Angeles, San Francisco, Chicago, Boston, Philadelphia, New York City, and Atlanta, the firm serves clients throughout North America, Europe, and Japan. For more information on Campbell Alliance, please visit http://www.campbellalliance.com.

CONTACT:

James Forte

Director, Public and Media Relations

Campbell Alliance

919-844-7100, extension 7195

jforte@campbellalliance.com


'/>"/>
SOURCE Campbell Alliance
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Biomedical Alliance about more than stem cells
2. Doyle seeks $2.5M for biomedical alliance
3. Alliance looks to create the right chemistry in SE Wisconsin
4. Biomedical alliance marks first full year
5. New alliance to provide Wi-Fi network for City of Madison
6. Budget axe could cut SE Wisconsin tech alliance funding
7. Biotech Alliance pushes ahead in SE Wisconsin with likely state funding
8. Milwaukee research alliance sees need for incubator
9. University alliance gets $2.5 million to encourage minorities in science and technology
10. Suite Scheduler Announces Alliance with Ice Technologies
11. Alliance Brings E-Business Technologies to Wisconsin Manufacturers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2017)... 2017 International research firm Parks Associates announced today ... the TMA 2017 Annual Meeting , October 11 in ... home security market and how smart safety and security products impact the ... Parks Associates: Smart Home Devices: ... "The residential security market has experienced ...
(Date:10/10/2017)... , ... October 10, 2017 , ... ... and business process optimization firm for the life sciences and healthcare industries, announces ... conference in San Francisco. , The presentation, “Automating GxP Validation for Agile Cloud ...
(Date:10/9/2017)... SAN DIEGO , Oct. 9, 2017 /PRNewswire/ ... a biological mechanism by which its ProCell stem ... of critical limb ischemia.  The Company, demonstrated that ... the amount of limbs saved as compared to ... of the molecule HGF resulted in reduction of ...
(Date:10/9/2017)... , ... October 09, 2017 , ... At its national ... Christopher Stubbs, a professor in Harvard University’s Departments of Physics and Astronomy, has been ... a member of the winning team for the 2015 Breakthrough Prize in Fundamental physics ...
Breaking Biology Technology:
(Date:8/15/2017)... Aug. 15 2017   ivWatch LLC , a medical device ... therapy, today announced receipt of its ISO 13485 Certification, the global ... International Organization for Standardization (ISO®). ... ivWatch Model 400 Continuous Monitoring device for the early detection of ... "This is an important milestone ...
(Date:6/14/2017)... IBM ) is introducing several innovative partner startups at ... between startups and global businesses, taking place in ... startups will showcase the solutions they have built with IBM ... France is one of the most ... increase in the number of startups created between 2012 and ...
(Date:5/6/2017)... 5, 2017 RAM Group , ... new breakthrough in biometric authentication based on a ... properties to perform biometric authentication. These new sensors are ... created by Ram Group and its partners. This sensor ... supply chains and security. Ram Group is a ...
Breaking Biology News(10 mins):